Clover Health Investments, Corp.

CLOV · Nasdaq · ·

Karşılaştır

$4,96+%0,711 Kas kapanış

30 Eylül 2026 tarihine kadarki rakamlar, 6 Kasım 2026 tarihinde sunulan 10-Q raporundan

1W: +%2,9
1M: +%3,1

Just reported

Q3 2026 results

From Clover Health Investments's results release of 4 Kasım 2026; its quarterly report has since been filed.

Revenue
Actual
$759,3M
+%53 y/y
+%2,2 q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0,01
-%80 q/q
Guided
—
No guide given
Operating income, GAAP
Actual
$6,4M
-%77 q/q
Guided
—
No guide given

Company outlook

Full year 2026

Revenue$2,97B – $3B+%55 y/y Raised +%0,8

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Clover Health Investments is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Healthcare Plans

Graded A or B and worth $2B or more: A first, then the largest.

All 11 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Tüm finansal tablolar →

Clover Health Investments, Corp. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

Clover Health Investments, Corp.

Clover Health Investments, Corp.

Q3 2026 results

Revenue

EPS, GAAP